Navigation Links
Sunshine pill for prostate cancer in 2009

A tablet designed to emulate the healing power of the sun could be available for the treatment of advanced prostate cancer as early as 2009. But it remains to be seen whether the drug will be the revolution in prostate cancer care that its makers claim.

The drug, Asentar (DN-101), is based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs. Drug makers came up with the idea because vitamin D from sunlight improves the prognosis of certain cancers. But taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose. If the on-going phase III trial goes to plan, the new drug should be available in 2009, reports Chemistry & Industry, the magazine of the SCI.

'If the results of the phase III trial are as good as those of the phase II trial, that would be significant,' says Nick James, professor of oncology at the University of Birmingham. In the phase II trials, Asentar significantly improved survival rates, 9 months over patients taking chemotherapy drugs (taxotere) alone. 'On average, patients in the advanced stage of the disease survive about 18 months, so an extension of 9 months would be very significant in my view,' says James.

Asentar provides levels of vitamin D 50-100 times higher than normal. Patients would be expected to take one tablet once a week with their weekly regime of taxotere for three weeks out of every four.

Business analysts say Asentar is a potential blockbuster, because prostate cancer rates are expected to soar in the next few years. But James is not so sure. 'A confounding factor is that if you go looking for more cases of cancer, you will find them. But this does not give you an accurate estimate of how many people will go on to develop advanced disease. In fact death rates are going down,
'"/>

Source:Society of Chemical Industry


Page: 1 2

Related biology news :

1. Mitochondrial DNA mutations play significant role in prostate cancer
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. Test for early detection of prostate cancer shows promise
4. U-M researchers identify new blood test for prostate cancer
5. U-M scientists say fused genes trigger the development of prostate cancer
6. Virus chip detects new virus in prostate tumors
7. Human prostate grown from embryonic stem cells
8. Curry and cauliflower could halt prostate cancer
9. Macrophage signaling may affect hormone resistance in prostate tumors
10. Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers
11. Vegetables inhibit growth of prostate cancer in mice with human tumors
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sunshine pill for prostate cancer

(Date:7/30/2014)... cells types. Researchers would like to understand how to channel ... make up the organs and other structures of living organisms. ... sugars that dangle from proteins on surfaces of cells. , ... has created synthetic molecules that can stand in for the ... the process, they report in the Journal of the ...
(Date:7/30/2014)... the first high-resolution map of the carbon stocks ... Per. The new and improved methodology used to ... future market-based carbon economies. The new carbon ... and it provides the critical input to studies ... use, and enforcement purposes. The technique includes the ...
(Date:7/29/2014)... USA The advanced optical methods and applications for ... a revolution in the neurosciences were the inspiration behind ... SPIE, the international society for optics and photonics. , ... BRAIN Initiative in the United States, and a special ... and provide examples of the impact that optics and ...
Breaking Biology News(10 mins):Peru's carbon quantified: Economic and conservation boon 2Peru's carbon quantified: Economic and conservation boon 3SPIE launches Neurophotonics journal with special section on BRAIN Initiative 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 3
... Memorial Sloan-Kettering Cancer Center have discovered that a new class ... work best in patients with mutations in the BRAF gene. ... the growth and survival of cancer cells and is mutated ... minority of patients with colon, breast, and lung cancers. The ...
... For the first time, ultrasound is being used in animal ... at the University of Pennsylvania School of Medicine completed a ... see a tumor's blood perfusion and then to treat it ... of treatment at an intensity similar to what is used ...
... week in Current Biology, tsunami damage to coral reefs ... was occasionally spectacular, but surprisingly limited, particularly when compared ... , Less than 100 days after the tsunami ... James Cook University, the Wildlife Conservation Society-Indonesia Program, and ...
Cached Biology News:Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs 2Penn researchers study the use of ultrasound for treatment of cancer 2
(Date:7/30/2014)... July 30, 2014. Applied DNA Sciences, ... provides DNA-based authentication and security solutions and services, has ... Life Sciences, a newly created position, with a starting ... lead APDN’s drive to build its business in pharmaceuticals ... customers, provide guidance to APDN’s R&D efforts, and apply ...
(Date:7/30/2014)... July 30, 2014  Dyadic International, Inc. ("Dyadic") ... patented and proprietary technologies are used to discover, ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... "Tom" Dubinski as Vice President and Chief Financial ... financial and information technology operations for Dyadic and ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 NCERC ... Athmanathan will present his findings on corn stover ... conference this week in Washington, D.C. , ... Energy conference is a testament to the success ... Caupert said. “Thanks to the foresight and vision ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 LayerBio, Inc., ... completion of its first round of seed financing from ... enable preliminary efforts to develop a novel sustained-release product ... of our investors and their commitment to this important ... LayerBio. "Ophthalmology is one of many areas in which ...
Breaking Biology Technology:Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3
... NORTH VANCOUVER, April 16 /PRNewswire-FirstCall/ - Chromos Molecular,Systems Inc. ... on its on-going restructuring efforts., The Board of ... stepped down as President and Chief Executive Officer, effective,immediately. ... Mr. Duncan, a,founder of the Company, served as President ...
... Annual Meeting of the American ... Association for Cancer Research (AACR) -, ... LOR; AMEX: LRP), a biopharmaceutical company specializing,in the research, ... management of cancer, today announced,presentations of further preclinical data ...
... the National Institute of Standards and Technology (NIST) ... on a single microchip, a cryogenic sensor and ... cheaper, simpler and faster precision analysis of materials ... in an upcoming issue of Applied Physics Letters,* ...
Cached Biology Technology:Chromos provides shareholder update 2Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040 2Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040 3Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040 4NIST micro sensor and micro fridge make cool pair 2
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
Recommended for supporting the growth of anchorage-dependent cells including human and mouse stromal cells, mesenchymal cells and cell lines....
ID clarifier: With ethidium bromide (50 μg/ml)...
... Propidium Iodide (PI) is a fluorescent nucleic ... nucleic acids. As a nuclear counterstain, ... dark red in color. The fluorescent ... or blue fluorochromes such as FITC, Cy2 ...
Biology Products: